延安必康(002411.SZ)下屬潤祥醫藥申請2.8億元授信業務
格隆匯3月9日丨延安必康(002411.SZ)公佈,公司於2020年3月9日召開第四屆董事會第四十五次會議、第四屆監事會第三十九次會議,審議通過了《關於公司及全資子公司為下屬子公司向銀行申請授信提供擔保的議案》、《關於實際控制人及其配偶為公司下屬子公司向銀行申請授信提供擔保暨關聯交易的議案》,其中《關於公司及全資子公司為下屬子公司向銀行申請授信提供擔保的議案》尚需提交公司2020年第三次臨時股東大會審議。
公司下屬子公司必康潤祥醫藥河北有限公司(“潤祥醫藥”)向北京銀行石家莊分行申請人民幣2.8億元授信業務,其中保證金不低於人民幣1.2億元。
公司實際控制人李宗鬆及其配偶擬無償為保證金以外的全部授信額度提供個人連帶責任保證擔保,保證期間為主合同下的債務履行期屆滿之日起三年,擔保金額為1.6億元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.